Dr. Hoenle AG (HNL) Financial Statements
Dr. Hoenle AG Financial Overview
Dr. Hoenle AG's market cap is currently $41.02M. The company's EPS TTM is $-0.48; its P/E ratio is -15.64; Dr. Hoenle AG has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Sep 25 | Sep 24 | Sep 23 | Sep 22 | Sep 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 93.68M | $ 98.73M | $ 106.34M | $ 116.09M | $ 115.17M |
| Gross Profit | $ 12.47M | $ 60.07M | $ 53.35M | $ 69.28M | $ 69.34M |
| Operating Income | $ -1.16M | $ -10.26M | $ -9.42M | $ 5.84M | $ 349.00K |
| EBITDA | $ 6.00M | $ 3.02M | $ 779.00K | $ 20.41M | $ 14.02M |
| Net Income | $ -3.17M | $ -13.28M | $ -11.01M | $ -13.36M | $ -4.82M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 7.75M | $ 7.51M | $ 9.32M | $ 7.13M | $ 12.07M |
| Total Assets | $ 145.52M | $ 155.38M | $ 176.16M | $ 195.46M | $ 202.91M |
| Total Debt | $ 48.25M | $ 53.24M | $ 56.89M | $ 59.53M | $ 53.64M |
| Net Debt | $ 40.50M | $ 45.73M | $ 47.57M | $ 52.40M | $ 41.57M |
| Total Liabilities | $ 68.48M | $ 75.70M | $ 80.02M | $ 88.22M | $ 91.78M |
| Stockholders' Equity | $ 76.87M | $ 79.42M | $ 95.82M | $ 106.88M | $ 110.72M |
| Cash Flow | |||||
| Free Cash Flow | $ 3.17M | $ 3.44M | $ 209.00K | $ -11.71M | $ -15.96M |
| Operating Cash Flow | $ 5.06M | $ 5.53M | $ 3.14M | $ -7.41M | $ 1.13M |
| Investing Cash Flow | $ 1.49M | $ -2.37M | $ 2.65M | $ -1.69M | $ -24.50M |
| Financing Cash Flow | $ -6.44M | $ -4.90M | $ -3.42M | $ 3.73M | $ 1.25M |
Currency in EUR
